Clinical trial

Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2

NCT02229734

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-12-01

PhasePHASE2

Study timeline

Study start (unknown)2014-12-01Date precision: month

Registry last updated2021-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

RadiationRADIATION

Androgen SuppressionDRUG

Sponsors & collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'slead sponsor

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02229734 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.